It also performs slightly better in the diagnosis of NAFLD severity than classical liver disease markers, including aspartate aminotransferase (AST), ALT and plasma caspase generated cytokeratin-18 fragments. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.